Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin Alfa Day 2 vs Day 4 in IVF
NCT01633580Phase 4
Key facts
- Status
- Completed
- Start
- Dec 2011
- Primary completion
- Mar 2013
- Countries
- 1
- Sponsor
- UZ Brussel
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Drugs
- corifollitropin alfa
- Conditions
- infertility
01
Overview
Phase 4, randomised, open-label trial of corifollitropin alfa in infertility (2 arms), sponsored by UZ Brussel. Primary endpoint: Consumption of rFSH at the end of the follicular phase up to 9 months. Started Dec 2011; status: completed.
02
Design
2 arms- Study design
- RandomizedOpen-label
Day 2 group
Corifollitropin alfa started on cycle day 2
Day 4 group
Corifollitropin alfa started on cycle day 4
03
Endpoints
Primary
Consumption of rFSH at the end of the follicular phase
Secondary
Pregnancy rate
Beyond the preview
Go deeper on NCT01633580.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01633580.